Aptima
Device Diagnostics
PDI 15420045500051
General payments
$3,526,678
Research payments
$11,057,696
Through program year 2025, $3,526,678 in general payments and $11,057,696 in research payments were reported against Aptima (Diagnostics).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
10 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $964,774 | 15,651 |
| 2025 | Research | $1,014,847 | 48 |
| 2024 | General | $1,086,018 | 15,224 |
| 2024 | Research | $730,585 | 63 |
| 2023 | General | $921,442 | 10,950 |
| 2023 | Research | $5,747,438 | 218 |
| 2022 | General | $353,314 | 7,927 |
| 2022 | Research | $2,897,110 | 100 |
| 2021 | General | $201,130 | 4,963 |
| 2021 | Research | $667,715 | 25 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 129 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 53 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
54,715 general · 454 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.